22.39% | % of shares held by all insiders |
72.57% | % of shares held by institutions |
93.50% | % of float held by institutions |
359 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
SB Investment Advisers (UK) LTD | 73,031,667 | 31 Mar 2024 | 9.89% | 689,711,080 |
Viking Global Investors, L.P. | 69,368,961 | 31 Mar 2024 | 9.39% | 655,120,484 |
QVT Financial LP | 66,719,779 | 31 Mar 2024 | 9.03% | 630,101,609 |
Blackrock Inc. | 36,187,519 | 31 Mar 2024 | 4.90% | 341,754,938 |
Morgan Stanley | 35,635,501 | 31 Mar 2024 | 4.82% | 336,541,680 |
FMR, LLC | 35,340,563 | 31 Mar 2024 | 4.78% | 333,756,285 |
Rubric Capital Management LP | 20,000,000 | 31 Mar 2024 | 2.71% | 188,880,004 |
State Street Corporation | 17,153,134 | 31 Mar 2024 | 2.32% | 161,994,201 |
Patient Square Capital LP | 12,228,465 | 31 Mar 2024 | 1.66% | 115,485,626 |
Woodline Partners LP | 11,172,306 | 31 Mar 2024 | 1.51% | 105,511,260 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Fidelity Growth Company Fund | 14,430,922 | 31 May 2024 | 1.95% | 136,285,630 |
iShares Core S&P Midcap ETF | 10,545,001 | 30 June 2024 | 1.43% | 99,586,992 |
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 8,332,440 | 30 June 2024 | 1.13% | 78,691,565 |
Vanguard Extended Market Index Fund | 5,085,818 | 31 Mar 2024 | 0.69% | 48,030,466 |
Fidelity Growth Company K6 Fund | 4,815,666 | 31 May 2024 | 0.65% | 45,479,150 |
Fidelity Series Growth Company Fund | 3,833,600 | 31 May 2024 | 0.52% | 36,204,519 |
Morgan Stanley Inst Fd Inc-Growth Port | 3,789,733 | 31 Mar 2024 | 0.51% | 35,790,239 |
Invesco ETF Tr-Invesco S&P MidCap Quality ETF | 3,733,634 | 30 June 2024 | 0.51% | 35,260,440 |
iShares Biotechnology ETF | 3,772,474 | 30 June 2024 | 0.51% | 35,627,245 |
Fidelity Select Portfolios - Biotechnology | 3,422,619 | 31 May 2024 | 0.46% | 32,323,214 |